BAC — Camsing Healthcare Income Statement
0.000.00%
Last trade - 00:00- SG$3.69m
- SG$7.40m
- SG$4.78m
Annual income statement for Camsing Healthcare, fiscal year end - January 31st, SGD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5.69 | 5.53 | 6.1 | 4.85 | 4.78 |
| Cost of Revenue | |||||
| Gross Profit | 3.38 | 2.83 | 3.51 | 2.98 | 2.74 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.52 | 6.88 | 8.51 | 7.58 | 5.66 |
| Operating Profit | -0.829 | -1.35 | -2.4 | -2.72 | -0.881 |
| Net Income Before Taxes | -0.829 | -1.35 | -2.4 | -2.72 | -0.881 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.829 | -1.33 | -2.4 | -2.72 | -0.881 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.828 | -1.33 | -2.4 | -2.72 | -0.881 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.828 | -1.33 | -2.4 | -2.72 | -0.881 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.054 | -0.044 | -0.083 | -0.085 | -0.022 |